QLT Could Pay Mass. Hospital $113M In Visudyne Case
The U.S. Court of Appeals for the First Circuit affirmed a judgment holding the Canadian biopharmaceutical company liable under Massachusetts state law for unfair trade practices and unjust enrichment for the sale of Visudyne, a treatment for macular degeneration and other eye diseases.
The court remanded an award of...
To view the full article, register now.